-
Physician Views Off-Label Use A 'Double-Edged Sword' For TG Therapeutics
Friday, April 21, 2017 - 10:57am | 420Reni Benjamin of Raymond James maintains a Strong Buy rating on TG Therapeutics Inc (NASDAQ: TGTX) after hosting an investor meeting with Charles Farber, a notable physician at the Summit Medical Group. Benjamin noted Farber's practice treats approximately 80 patients per week who suffer from...